The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-13 of 13 articles
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
Kerkmeijer L,
Renkens M,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Garcia-Garcia H,
Kraak R,
Piek J,
Tijssen J,
Henriques JP,
de Winter RJ,
Wykrzykowska JJ
March 18, 2022 | 10.4244/EIJ-D-21-00419
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial
Kraak R,
Tijssen R,
van Dongen I,
Elias J,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Tijssen J,
Piek J,
de Winter RJ,
Henriques JP,
Wykrzykowska JJ
December 4, 2020 | 10.4244/EIJ-D-18-00884
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska JJ,
de Winter RJ,
Hamm C,
Steg PG,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial
Smits P,
Chang C,
Chevalier B,
West N,
Gori T,
Barbato E,
Tarantini G,
Kocka V,
Achenbach S,
Dudek D,
Escaned J,
Wlodarczak A,
Abdel-Wahab M,
Esposito G,
Tijssen J,
Morice M,
Onuma Y,
van Geuns R
October 23, 2020 | 10.4244/EIJ-D-19-01079
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial
Tomaniak M,
Chichareon P,
Modolo R,
Takahashi K,
Chang C,
Kogame N,
Spitzer E,
Buszman P,
van Geuns R,
Valkov V,
Steinwender C,
Geisler T,
Prokopczuk J,
Sabaté M,
Zmudka K,
Rademaker-Havinga T,
Tijssen J,
Jüni P,
Hamm C,
Steg PG,
Onuma Y,
Vranckx P,
Valgimigli M,
Windecker S,
Baber U,
Anderson R,
Dominici M,
Serruys P
April 3, 2020 | 10.4244/EIJ-D-19-00699
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
Serruys P,
Tomaniak M,
Chichareon P,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Spitzer E,
Walsh S,
Adlam D,
Hildick-Smith D,
Édes I,
van de Harst P,
Krackhardt F,
Tijssen J,
Rademaker-Havinga T,
Garg S,
Steg PG,
Hamm C,
Jüni P,
Vranckx P,
Onuma Y,
Verheugt F
December 20, 2019 | 10.4244/EIJ-D-19-00202
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
Kerkmeijer L,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout K,
Kraak R,
Weevers A,
Piek J,
de Winter RJ,
Tijssen J,
Henriques J,
Wykrzykowska JJ,
Ijsselmuiden A,
Kauer F,
Beijk MA,
Vis MM,
Koch K
September 20, 2019 | 10.4244/EIJ-D-19-00325
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI
Tijssen R,
Kraak R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Elias J,
van Dongen I,
Koch K,
Baan Jr J,
Vis MM,
de Winter RJ,
Piek J,
Tijssen J,
Henriques J,
Wykrzykowska JJ
July 20, 2018 | 10.4244/EIJ-D-18-00335
Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial
Tijssen R,
Kraak R,
Elias J,
van Dongen I,
Kalkman D,
Nassif M,
Sotomi Y,
Asano T,
Katagiri Y,
Collet C,
Piek J,
Henriques J,
de Winter RJ,
Tijssen J,
Onuma Y,
Serruys P,
Wykrzykowska JJ
July 20, 2018 | 10.4244/EIJ-D-17-01152
Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial
Teeuwen K,
Spoormans E,
Bennett J,
Dubois C,
Desmet W,
Ughi G,
Belmans A,
Kelder J,
Tijssen J,
Agostoni P,
Suttorp MJ,
Adriaenssens T
August 4, 2017 | 10.4244/EIJ-D-17-00261
Latest news
AHEAD OF PRINT
Physiological changes post-CTO PCI and predictors
FREE ARTICLE - Sarosh A Khan et al
February 1, 2023
AHEAD OF PRINT
In-stent neoatherosclerosis in LEAD
FREE ARTICLE - Arne Müller et al
January 30, 2023
NEW ISSUE
M-TEER State-of-the-Art; Comparing ACURATE Neo2 to Evolut PRO/PRO + and the SAPIEN 3 Ultra; Mini Focus on Vulnerable Plaque: Plaque Composition and Vulnerability – Radial Wall Strain...
January 23, 2023
AHEAD OF PRINT
Cerebral embolic protection in TAVI
FREE ARTICLE - Rajesh K. Kharbanda et al
January 26, 2023
AHEAD OF PRINT
First experience of LAAO using a 3D mini TOE probe with conscious sedation
FREE ARTICLE - Laura Sanchis et al
January 25, 2023
AHEAD OF PRINT
“Lotus root”: a novel OCT imaging pattern in spontaneous coronary artery dissection
FREE ARTICLE - David del Val et al
January 20, 2023
AHEAD OF PRINT
Antiplatelet therapy following PCI for stable CAD
FREE ARTICLE - Anoop N. Koshy et al
January 19, 2023